Note 12 - Segment and Geographic Information - Operating Segment Reconciliation to Net Income (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||
| Net sales | $ 64,232 | $ 55,849 | $ 124,103 | $ 109,327 | ||||
| Cost of sales | 19,258 | 17,381 | 37,709 | 34,194 | ||||
| Gross profit | 44,974 | 38,468 | 86,394 | 75,133 | ||||
| Research and development expense | 3,541 | 4,284 | 7,636 | 8,376 | ||||
| Net income | 13,779 | $ 11,011 | 11,826 | $ 9,887 | 24,790 | 21,713 | ||
| Operating Segments [Member] | ||||||||
| Net sales | 64,232 | 55,849 | 124,103 | 109,327 | ||||
| Cost of sales | 19,258 | 17,381 | 37,709 | 34,194 | ||||
| Gross profit | 44,974 | 38,468 | 86,394 | 75,133 | ||||
| Selling expense | 13,579 | 9,796 | 26,403 | 20,348 | ||||
| Marketing expense | 1,316 | 1,188 | 2,704 | 2,322 | ||||
| Administrative expense | 7,177 | 5,972 | 14,000 | 11,868 | ||||
| Finance expense | 2,481 | 2,276 | 5,449 | 4,814 | ||||
| Management information systems expense | 738 | 572 | 1,434 | 1,151 | ||||
| Research and development expense | 1,113 | 830 | 2,214 | 1,662 | ||||
| Process engineering expense | 543 | 735 | 1,282 | 1,540 | ||||
| Regulatory and clinical expense | 1,885 | 2,719 | 4,140 | 5,174 | ||||
| Other (income) expense, net* | [1] | 2,363 | 2,554 | 3,978 | 4,541 | |||
| Net income | $ 13,779 | $ 11,826 | $ 24,790 | $ 21,713 | ||||
| ||||||||
| X | ||||||||||
- Definition The amount of administrative expense. No definition available.
|
| X | ||||||||||
- Definition The amount of finance expense. No definition available.
|
| X | ||||||||||
- Definition The amount of management information systems expense. No definition available.
|
| X | ||||||||||
- Definition The amount of other income (expense), net. No definition available.
|
| X | ||||||||||
- Definition The amount of process engineering expense. No definition available.
|
| X | ||||||||||
- Definition The amount of regulatory and clinical expense. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|